“We welcome Gilead’s statement of commitment to non-profit pricing,” remarks @unaids Winnie Byanyima, “but we had been waiting eagerly for a specific price. Respected researchers showed it is possible for $100 per patient per year, falling to $40.” unaids.org/en/resources/p…

We welcome Gilead Sciences' announcement of licensing the break-through HIV medicine lenacapavir for generic production. To stem the tide of new infections, and protect people most at risk from HIV, including young women & people from marginalised communities, long-acting HIV

‘Gamechanger’ #HIV prevention drug to be made available cheaply in 120 countries. Gilead announces deal to manufacture generic versions of #lenacapavir, but critics say it excludes many countries where incidence is highest, by Kat Lay theguardian.com/global-develop… via The Guardian #PrEP

Guardian highlights @unaids Winnie Byanyima’s call on Gilead to share licenses for the new game-changing twice-a-year-injection HIV prevention with all low and middle income countries, and to say what the price will be. theguardian.com/global-develop…

Campaigners said the deal “abandons” many countries with a high HIV burden, particularly in Latin America, and urged transparency over exact pricing. Important reporting from Kat Lay, with comment from Mohga Kamal-Yanni and Winnie Byanyima theguardian.com/global-develop…

WHO urges Gilead Sciences to ensure new HIV medicine lenacapavir is "available and affordable in all countries; including where new HIV infections are on the rise" But 41% of new infections are in upper-middle-income countries (per UNAIDS Global) And Gilead is abandoning most of them

We applaud Gilead Sciences for licensing lenacapavir w/o waiting for registration. But last year, 41% of new HIV infections were in upper middle-income countries—excluding many of them from the licences undermines potential of this scientific breakthrough. theguardian.com/global-develop…

#Lenacapavir has the potential to transform #HIV prevention, but only if it is made truly accessible to everyone who needs it, without restrictions and exclusions. Gilead Sciences VL will prevent millions of people from accessing #LEN. Read more: ⚡️💉👇🏿 tinyurl.com/52px2tn5

Es una suerte contar con una organización como Salud por Derecho que empujan desde su lugar para avanzar en términos de salud global. Su último texto sobre las licencias voluntarias de lenacapavir es un gran ejemplo. saludporderecho.org/lenacapavir-la…

Can’t believe that turning the care of the vulnerable over to profit-making corporations leads to profits for corporations and harm to the vulnerable …

Really keen to hear from others who are actively working on the role of private equity funds and broader financialisation of health and care services and trying to influence governments with the evidence against (anywhere in the world). Please message me. theguardian.com/society/2024/o…

Huh that’s weird. Never could have seen this coming.

“Generics in all low- & middle-income countries are essential. But ViiV continues to lock out many,” says @unaids @winnie_byanyima. “Shockingly, they even launched a legal challenge against Colombia for trying to access a generic lifesaving HIV medicine.” unaids.org/en/resources/p…

To ensure access for everyone who needs these breakthrough medicines, generic versions are essential in all low- & middle-income countries. But ViiV Healthcare continues to lock out many of these countries. Shockingly, they even launched a legal challenge against 🇿🇦 Colombia for trying

This is such an honor! At #DemocracySummit2024. That today focuses on that word we don’t talk about: oligarchy. Ida Bae Wells - who’s brought reporters across the country together - opens up. I'm on at 10am. With Nope. and AndreaBNYC. Live now youtube.com/live/QkcVTrw2c…

Most British thing I've ever heard. The service isn't there to be a service, the service is there as a low-level entrapment scam.

This #DayoftheGirl, let’s stand with “‘girls’ vision for the future"—a future where they have access to education, information, and health services to stay safe and pursue their dreams. To protect girls’ health, protect girls’ rights.

One aside from the Grenfell Tower Inquiry report not widely picked up. The panel has concluded that the reason for cladding Grenfell was aesthetics, not insulation. Really does emphasise how this was a story about class.

Powerful interview by UNAIDS Executive Director Winnie Byanyima in El Pais. To end AIDS: Share technology, drop debt, and protect the human rights of women and of LGBTQ+ people. To make this happen: pressure from people power. elpais.com/planeta-futuro…

“We agree with World Bank that ordinary people across the world are facing a lost decade, which will scar a whole generation, but at the same time the richest are looking at their best decade ever and these two things are closely linked" - Max Lawson. theguardian.com/business/2024/…